Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Depreciation and Depletion (2021 - 2025)

Historic Depreciation and Depletion for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $21807.0.

  • Verrica Pharmaceuticals' Depreciation and Depletion fell 7819.3% to $21807.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $208807.0, marking a year-over-year decrease of 5420.9%. This contributed to the annual value of $342000.0 for FY2024, which is 3547.17% down from last year.
  • Latest data reveals that Verrica Pharmaceuticals reported Depreciation and Depletion of $21807.0 as of Q3 2025, which was down 7819.3% from $45000.0 recorded in Q2 2025.
  • Verrica Pharmaceuticals' Depreciation and Depletion's 5-year high stood at $177000.0 during Q4 2022, with a 5-year trough of $11000.0 in Q1 2021.
  • Over the past 5 years, Verrica Pharmaceuticals' median Depreciation and Depletion value was $100000.0 (recorded in 2023), while the average stood at $91568.8.
  • As far as peak fluctuations go, Verrica Pharmaceuticals' Depreciation and Depletion skyrocketed by 79090.91% in 2022, and later crashed by 7819.3% in 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Depreciation and Depletion (Quarter) stood at $142000.0 in 2021, then grew by 24.65% to $177000.0 in 2022, then fell by 26.55% to $130000.0 in 2023, then crashed by 67.69% to $42000.0 in 2024, then tumbled by 48.08% to $21807.0 in 2025.
  • Its Depreciation and Depletion stands at $21807.0 for Q3 2025, versus $45000.0 for Q2 2025 and $100000.0 for Q1 2025.